Bio-Vascular
This article was originally published in The Gray Sheet
Executive Summary
Inks non-exclusive agreement to provide InterVentional Technologies with a "stent cover" for pre-clinical and clinical studies designed to evaluate how the material affects stent performance. Bio-Vascular also will provide covers in commercial quantities following regulatory approval. IVT is responsible for obtaining market clearance and evaluating the cover for impact on restenosis and perforation rates, as well as effects on downstream debris during placement. IVT's LP stent, which recently received the CE mark, already incorporates the cover
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.